review Open AccessTop 1% cited
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases · 2015 · Vol. 75(1) · pp. 3–15
Josef S Smolen✉(Klinik Hietzing)Ferdinand C. Breedveld(Leiden University Medical Center)Gerd R Burmester(Humboldt-Universität zu Berlin)Vivian P. Bykerk(Hospital for Special Surgery)Maxime Dougados(Délégation Paris 5)Paul Emery(University of Leeds)Tore K Kvien(Diakonhjemmet Hospital)M Victoria Navarro-Compán(Leiden University Medical Center)Susan Oliver(Nolan Associates (United Kingdom))Monika Schoels(Klinik Hietzing)Marieke Voshaar(European League Against Rheumatism)Tanja Stamm(Medical University of Vienna)Michaela Stoffer(Medical University of Vienna)Tsutomu Takeuchi(Keio University)Daniel Aletaha(Medical University of Vienna)José Luís Andreu(Hospital Universitario Puerta de Hierro Majadahonda)Martin Aringer(Technische Universität Dresden)Martin Bergman(Drexel University)Neil Betteridge(European League Against Rheumatism)Hans Bijlsma(University Medical Center Utrecht)Harald Burkhardt(Goethe University Frankfurt)Myrna Cardiel(Universidad de Morelia)Bernard Combe(Université de Montpellier)Patrick Durez(Cliniques Universitaires Saint-Luc)João Eurico Fonseca(University of Lisbon)A. Gibofsky(Hospital for Special Surgery)Juan J. Gómez‐ReinoW. Graninger(Medical University of Graz)Pekka Hannonen(Central Finland Health Care District)Boulos Haraoui(Montreal Clinical Research Institute)Marios Kouloumas(European League Against Rheumatism)Robert Landewé(Amsterdam UMC Location University of Amsterdam)E. Martín‐Mola(Hospital Universitario La Paz)Peter Nash(The University of Queensland)Mikkel Østergaard(University of Copenhagen)Andrew J.K. Östör(University of Cambridge)P. Scott Richards(European League Against Rheumatism)Tuulikki Sokka‐Isler(Central Finland Health Care District)Carter Thorne(Southlake Regional Health Center)Athanasios G. Tzioufas(National and Kapodistrian University of Athens)Ronald van Vollenhoven(Karolinska University Hospital)M. De Wit(European League Against Rheumatism)Désirée van der Heijde(Leeds Teaching Hospitals NHS Trust)
Abstract
The 4 overarching principles and 10 recommendations are based on stronger evidence than before and are supposed to inform patients, rheumatologists and other stakeholders about strategies to reach optimal outcomes of RA.
Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchViral Infections and Immunology ResearchMedicineTask forceRheumatoid arthritisTask (project management)Physical therapyImmunologyManagement
MeSH terms
Arthritis, RheumatoidHumansTerminology as TopicPatient Care PlanningPatient ParticipationRemission InductionSeverity of Illness IndexComorbidityAntirheumatic AgentsEvidence-Based MedicineMaintenance Chemotherapy
Funding
- Universität Wien
- Medizinische Universität Wien
Citations
1,431
FWCI
118.80
field-weighted impact
References
132
Percentile
100%
vs. same field & year
Citations per year
Cited by
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
European Journal of Medicinal Chemistry · 2018 · 541 citations
Tocilizumab: A Review in Rheumatoid Arthritis
Drugs · 2017 · 403 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Annals of the Rheumatic Diseases · 2022 · 1,636 citations
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Annals of the Rheumatic Diseases · 2016 · 910 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · 5,757 citations
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Annals of the Rheumatic Diseases · 2020 · 935 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Annals of the Rheumatic Diseases · 2020 · 2,709 citations
References
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Arthritis & Rheumatism · 2011 · 1,015 citations
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Lara D. Veeken · 2009 · 355 citations
Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
Arthritis & Rheumatism · 1995 · 6,175 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · 5,757 citations
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
Lara D. Veeken · 2003 · 1,048 citations
Treating rheumatoid arthritis to target: recommendations of an international task force
Annals of the Rheumatic Diseases · 2010 · 2,076 citations
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Arthritis & Rheumatism · 1995 · 2,833 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Annals of the Rheumatic Diseases · 2013 · 1,756 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
